Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
暂无分享,去创建一个
R. Brookmeyer | R. Stuart | H. Braine | G. Elfenbein | L. Sensenbrenner | A. Yeager | W. Bias | R. Saral | G. Santos | H. Kaizer | W. Burns | P. Tutschka | W. Beschorner | D. Mellits
[1] B. Bean,et al. Acyclovir halts progression of herpes zoster in immunocompromised patients. , 1983, The New England journal of medicine.
[2] D. Findley,et al. Bone Marrow Ablation Followed by Allogeneic Marrow Grafting During First Complete Remission of Acute Nonlymphocytic Leukemia , 1983 .
[3] A. Hess,et al. Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. , 1983, Blood.
[4] A. Rimm,et al. BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA IN FIRST REMISSION , 1982, The Lancet.
[5] N. Flournoy,et al. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. , 1982, Reviews of infectious diseases.
[6] H. Braine,et al. Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion , 1982 .
[7] W. Woods,et al. Allogeneic bone marrow transplantation in acute nonlymphocytic leukemia: a pilot study. , 1982, Blood.
[8] G. Santos,et al. Bone marrow transplantation in acute leukemia. , 1982, Seminars in hematology.
[9] R. Yolken,et al. Infectious gastroenteritis in bone-marrow-transplant recipients. , 1982, The New England journal of medicine.
[10] Ron Brookmeyer,et al. A Confidence Interval for the Median Survival Time , 1982 .
[11] O. Laskin,et al. Acyclovir prophylaxis of herpes-simplex-virus infections. , 1981, The New England journal of medicine.
[12] K. Sullivan,et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.
[13] D. Hedley,et al. THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.
[14] J. Boitnott,et al. Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. , 1980, The American journal of pathology.
[15] P. Neiman,et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.
[16] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[17] D. L. Klein,et al. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide. , 1976, Transplantation proceedings.
[18] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[19] R. Slavin,et al. The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. , 1973, Clinical immunology and immunopathology.
[20] R. Slavin,et al. The use of cyclophosphamide for clinical marrow transplantation. , 1972, Transplantation proceedings.
[21] R Storb,et al. Technique for human marrow grafting. , 1970, Blood.
[22] D. Karnofsky. Meaningful clinical classification of therapeutic responses to anticancer drugs , 1961, Clinical pharmacology and therapeutics.
[23] K. Sullivan,et al. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia in relapse using fractionated total body irradiation. , 1982, Leukemia research.
[24] K. Sullivan,et al. Allogeneic marrow transplantation for patients with acute non-lymphoblastic leukemia in second remission. , 1982, Leukemia research.